Trial Profile
A Phase I Study Of PS-341 In Combination With Gemcitabine And Carbloplatin In Selected Stage IIIB Or IV Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Carboplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2008 New trial record.